UM

Browse/Search Results:  1-4 of 4 Help

Selected(0)Clear Items/Page:    Sort:
Exploiting new strategies in combating head and neck carcinoma: A comprehensive review on phytochemical approaches passing through PI3K/Akt/mTOR signaling pathway Journal article
Iranpanah, Amin, Majnooni, Mohammad Bagher, Biganeh, Hossein, Amirian, Roshanak, Rastegari-Pouyani, Mohsen, Filosa, Rosanna, Cheang, Wai San, Fakhri, Sajad, Khan, Haroon. Exploiting new strategies in combating head and neck carcinoma: A comprehensive review on phytochemical approaches passing through PI3K/Akt/mTOR signaling pathway[J]. Phytotherapy Research, 2024, 38(7), 3736-3762.
Authors:  Iranpanah, Amin;  Majnooni, Mohammad Bagher;  Biganeh, Hossein;  Amirian, Roshanak;  Rastegari-Pouyani, Mohsen; et al.
Favorite | TC[WOS]:0 TC[Scopus]:1  IF:6.1/7.0 | Submit date:2024/09/03
Cancer  Head And Neck  Phytochemical  Pi3k/akt/mtor Pathway  
Roles of Major RNA Adenosine Modifications in Head and Neck Squamous Cell Carcinoma Review article
2021
Authors:  Xing-xing Huo;  Shu-jie Wang;  Hang Song;  Ming-de Li;  Hua Yu; et al.
Favorite | TC[WOS]:5 TC[Scopus]:5  IF:4.4/5.0 | Submit date:2022/08/29
Rna Modification  n 6-methyladenosine  n 1-methyladenosine  Alternative Polyadenylation  Adenosineto-inosine Editing  Head And Neck Squamous Cell Carcinoma  Immunotherapy  
Amide proton transfer-weighted imaging of the head and neck at 3 T: A feasibility study on healthy human subjects and patients with head and neck cancer Journal article
Yuan J., Chen S., King A.D., Zhou J., Bhatia K.S., Zhang Q., Yeung D.K.W., Wei J., Mok G.S.P., Wang Y.-X.. Amide proton transfer-weighted imaging of the head and neck at 3 T: A feasibility study on healthy human subjects and patients with head and neck cancer[J]. NMR in Biomedicine, 2014, 27(10), 1239.
Authors:  Yuan J.;  Chen S.;  King A.D.;  Zhou J.;  Bhatia K.S.; et al.
Favorite | TC[WOS]:54 TC[Scopus]:60 | Submit date:2018/10/30
Amide Proton Transfer (Apt)  Asymmetric Magnetization Transfer Ratio  Chemical Exchange Saturation Transfer (Cest)  Head And Neck Tumor  Parotid Gland  
A phase II study of hydroxyurea combined with gemcitabine in patients with head and neck squamous carcinoma and gene expression profiles correlated to poor response Journal article
Zhang K., Kim C., Wu X., Loera S., Wang Y., Chu P., Lim D., Shibata S., Yen Y.. A phase II study of hydroxyurea combined with gemcitabine in patients with head and neck squamous carcinoma and gene expression profiles correlated to poor response[J]. Head and Neck Oncology, 2013, 5(3).
Authors:  Zhang K.;  Kim C.;  Wu X.;  Loera S.;  Wang Y.; et al.
Favorite |  | Submit date:2019/01/16
Gene expression profile  Head and neck squamous cell carcinoma (HNSCC)  Hydroxyurea and gemcitabine